Hain Lifescience is now “a Bruker Company”
With the acquisition of a majority interest in Hain Lifescience GmbH, Bruker further expands its product portfolio in the area of Molecular Diagnostics. The business of Hain Lifescience will be continued as part of the Bruker Corporation. The new management team includes Dr. Wolfgang Pusch, David Hain and Tobias Hain.
Management Team, from left to right: Tobias Hain, Wolfgang Pusch and David Hain
In addition to the well-known names in the management team, a number of constants will remain for our customers, distributors and partners: You can continue to rely on our innovative molecular assays and devices, as well as our excellent service.
Here you find more information.